Zepbound: A Comprehensive Guide to Tirzepatide for Weight Loss and Obstructive Sleep Apnea
Zepbound, the brand name for tirzepatide, is a revolutionary injectable medication developed by Eli Lilly. Approved by the U.S. Food and Drug Administration (FDA), Zepbound offers a novel approach to managing obesity and related conditions. Unlike traditional treatments, Zepbound targets two key hormones—glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)—to enhance weight loss and improve…